Remove Advisory Remove Capital Market Remove Entertainment
article thumbnail

Cooley’s 2022 Life Sciences M&A Year in Review

Cooley M&A

2022 drivers and headwinds Choppy access to capital markets and financing to fund ongoing operations Many life sciences companies faced challenges raising money in the capital markets in 2022. Let’s dig in.

M&A 40
article thumbnail

Selling a Repair Shop for Maximum Profit

Focus Investment Banking

We also do buy side for some larger entities and now were really making a push on capital raises and the capital markets as well. Theres a lot of Capital gains and tax advisory that needs to go into it. While we dont do tax advisory, we have a general understanding of it and can recommend others.